Research map: PTX3 induces the expression of PD-L1 and promotes breast cancer immune escape

Back to the article

Papers in this map

  1. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients · Roy S. Herbst · 2014 · 5363 citations · Cited by this paper
  2. Three cases of whole breast irradiation for breast cancer in patients with Lymphangioleiomyomatosis (LAM) · 2026 · Related
  3. PD-L1 Expression in Triple-Negative Breast Cancer · Elizabeth Ann Mittendorf · 2014 · 1437 citations · Cited by this paper
  4. Low protein, high risk: hypoalbuminemia predicts adverse outcomes after mastectomy in 37,848 breast cancer patients · 2026 · Related
  5. Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA · Matthew A. Coelho · 2017 · 688 citations · Cited by this paper
  6. BRCA1/2 Reversion Mutations in Japanese Patients with Metastatic Breast Cancer Progressing on Olaparib: OLIVE (WJOG15321B) · 2026 · Related
  7. An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm · Barbara Bottazzi · 2009 · 605 citations · Cited by this paper
  8. Fear of diagnosis as a barrier to the screening and diagnosis of breast cancer · 2026 · Related
  9. Clinical Challenges of Immune Checkpoint Inhibitors · Maria de Miguel · 2020 · 588 citations · Cited by this paper
  10. Quality of life in women with breast cancer undergoing chemotherapy: a comparative cross-sectional study of CICC ports and PICC-ports · 2026 · Related
  11. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches · Muhammad Tufail · 2025 · 347 citations · Cited by this paper
  12. Characteristics of a multigene assay (MammaPrint/Blueprint) to predict early recurrence of hormone receptor-positive, HER2-negative breast cancer: a case‒control study (WJOG16722B) · 2026 · Related
  13. Beclin 1, Bcl-2 and Autophagy · Haidong Xu · 2019 · 323 citations · Cited by this paper
  14. Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing · 2026 · Related
  15. Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade · Xiaoming Dai · 2021 · 264 citations · Cited by this paper
  16. Breast ultrasound screening in young adult women undergoing infertility treatment at an infertility clinic: a retrospective observational study · 2026 · Related
  17. β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion · Linyong Du · 2020 · 241 citations · Cited by this paper
  18. Minimal important differences of EORTC QLQ-C30 and QLQ-BR23 for metastatic breast cancer patients in a Japanese population: results from the RESQ trial · 2026 · Related
  19. PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies · Menglei Jin · 2024 · 144 citations · Cited by this paper
  20. Comparison of three arm-positioning techniques for minimizing motion artifacts in breast magnetic resonance imaging: a prospective volunteer study · 2026 · Related
  21. Regulation of autophagy by E3 ubiquitin ligase RNF216 through BECN1 ubiquitination · Chuanshan Xu · 2014 · 117 citations · Cited by this paper
  22. The moonlighting function of glycolytic enzyme enolase-1 promotes choline phospholipid metabolism and tumor cell proliferation · Qingxia Ma · 2023 · 114 citations · Cited by this paper
  23. Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway · Moeez Ghani Rathore · 2019 · 106 citations · Cited by this paper
  24. Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer · Giovanni Stallone · 2014 · 88 citations · Cited by this paper
  25. Long pentraxin 3: A novel multifaceted player in cancer · Arianna Giacomini · 2017 · 88 citations · Cited by this paper
  26. PD-1 regulation in immune homeostasis and immunotherapy · Minling Gao · 2024 · 75 citations · Cited by this paper
  27. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers · Yu‐Wei Hsiao · 2022 · 54 citations · Cited by this paper
  28. Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers · Clémence Thomas · 2017 · 52 citations · Cited by this paper
  29. Cytokine TNF-α promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3 · Xinye Cui · 2020 · 44 citations · Cited by this paper
  30. ADSL-generated fumarate binds and inhibits STING to promote tumour immune evasion · Yuran Duan · 2025 · 42 citations · Cited by this paper
  31. Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression · Sara Matarazzo · 2019 · 40 citations · Cited by this paper
  32. Insights into the Relationship between Pentraxin-3 and Cancer · Mária Bogdán · 2022 · 29 citations · Cited by this paper
  33. The relationship between autophagy and PD-L1 and their role in antitumor therapy · Yu Cui · 2023 · 27 citations · Cited by this paper
  34. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis · Hailun Xie · 2024 · 23 citations · Cited by this paper
  35. Regulation of programmed death ligand 1 (PD‐L1) expression by TNF‐related apoptosis‐inducing ligand (TRAIL) in triple‐negative breast cancer cells · Julio M. Pimentel · 2022 · 17 citations · Cited by this paper
  36. The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer · Arianna Giacomini · 2023 · 16 citations · Cited by this paper
  37. Post-translational governance of NF-κB in cancer immunity: mechanisms and therapeutic horizons · Yue Hong · 2025 · 16 citations · Cited by this paper
  38. Role of long pentraxin PTX3 in cancer · Duo Li · 2023 · 14 citations · Cited by this paper
  39. Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p/RGMA axis · Jie Lun · 2024 · 14 citations · Cited by this paper

Source: OpenAlex (CC0)